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Cutaneous aging is characterized by a decline in cellular energy metabolism, which is mainly caused by detrimental
changes in mitochondrial function. The processes involved seem to be predominantly mediated by free radicals
known to be generated by exogenous noxes, e.g., solar ultraviolet (UV) radiation. Basically, skin cells try to
compensate any loss of mitochondrial energetic capacity by extra-mitochondrial pathways such as glycolysis or
the creatine kinase (CK) system. Recent studies reported the presence of cytosolic and mitochondrial isoenzymes
of CK, as well as a creatine transporter in human skin. In this study, we analyzed the cutaneous CK system,
focusing on those cellular stressors known to play an important role in the process of skin aging. According to our
results, a stress-induced decline in mitochondrial energy supply in human epidermal cells correlated with a de-
crease in mitochondrial CK activity. In addition, we investigated the effects of creatine supplementation on human
epidermal cells as a potential mechanism to reinforce the endogenous energy supply in skin. Exogenous creatine
was taken up by keratinocytes and increased CK activity, mitochondrial function and protected against free oxygen
radical stress. Finally, our new data clearly indicate that human skin cells that are energetically recharged with the
naturally occurring energy precursor, creatine, are markedly protected against a variety of cellular stress condi-
tions, like oxidative and UV damage in vitro and in vivo. This may have further implications in modulating proc-
esses, which are involved in premature skin aging and skin damage.
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According to a widely accepted theory of aging, alterations
in mitochondrial function can be regarded both as an im-
portant cause, as well as a consequence of aging (Harman,
1956). A lack of mitochondrial function impairs cellular ATP
synthesis, and altered mitochondrial physiology can addi-
tionally induce the formation of free reactive oxygen species
(ROS), e.g., as by-products of an impaired mitochondrial
respiration (Sohal, 1991). Increased generation of ROS will
further damage neighboring mitochondrial protein complex-
es and enzymes, as well as membranes and DNA, and this
in turn might further accelerate the aging process.
Several of the well-known negative consequences of
solar radiation are mediated by ultraviolet (UV)-induced
generation of ROS (Scharffetter-Kochanek et al, 1997). In-
creasing levels of ROS lead to an enhanced redox signalling
and finally to the activation of specific target genes like
matrixmetalloproteinases, which in turn degrade dermal
collagen bundles and thus contribute to the formation of
facial wrinkles (Fisher et al, 1997). Physiologically, the cel-
lular level of ROS can be balanced and counteracted by an
effective endogenous antioxidant system (Sies, 1985).
Oxidative damage of cellular and extracellular com-
ponents activates intrinsic repair mechanisms, which
necessarily require ATP for full functionality. The PCr
(phosphocreatine)/CK (creatine kinase) system together
with the recently discovered epidermal creatine transport-
er (CRT) (Schlattner et al, 2002) provide human skin with an
important tool to cope efficiently with conditions of high-
energy demand. The free energy of ATP is stored and
transported in the form of PCr from sub-cellular sites of
energy production, e.g., mitochondria, to places of high-
energy requirements, where CK activity can replenish cel-
lular ATP in situ (Bessman and Carpenter, 1985; Wallimann
et al, 1992, 1998). Predominant isoforms of CK consist of
cytosolic MM-CK (muscle-type), mainly found in muscle
cells, as well as cytosolic BB-CK (brain-type) and ubiqui-
tous mitochondrial Mi-CK, with the last two mainly located
in the brain but also present in skin (Schlattner et al, 2002).
The importance of creatine and the CK system for normal
cell function has been elucidated in transgenic mice lacking
the expression of CK (Steeghs et al, 1997; Gorselink et al,
2001; Crozatier et al, 2002; Janssen et al, 2003). These an-
imals showed muscular and neurological dysfunctions and
Abbreviations: BB-CK, cytosolic brain-type (ubiquitous) CK; CK,
creatine kinase; CRT, creatine transporter; EM, emission; EX, ex-
citation; JC-1, 5,50,6,60-tetrachloro-1,10,3,30-tetraethyl-benzimidazol-
carbocyanine iodide; K(m), Michelis–Menten constant; Mi-CK,
mitochondrial CK; MM-CK, cytosolic muscle-type CK; MMP, mi-
tochondrial membrane potential; PBS, phosphate-buffered saline;
PCr, phosphocreatine; ROS, free reactive oxygen species; TCA,
trichloroacetic acid; UVA, ultraviolet A (320–400 nm)
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phenotypes that have some similarities with the clinical
symptoms of humans suffering from the so-called ‘‘creatine
deficiency syndrome’’ (Leuzzi, 2002).
Cells attain their physiological levels of creatine, either by
biosynthesis from the amino acids arginine, glycine, and
methionine in the kidney, liver, and pancreas of vertebrates
including humans (Walker, 1979), and/or alternatively by in-
gestion of meat and fish (Balsom et al, 1994). Creatine is
transported via the blood circulation and is taken up into
cells by a Naþ - and Cl-dependent CRT protein (Snow and
Murphy, 2001; Speer et al, 2004). Once inside a cell, crea-
tine can be stored at high concentrations (e.g., 40 mM for
muscle cells). In addition to this, creatine is well known for
its protective effects in the treatment of neurological and
atherosclerotic diseases (Wyss and Schulze, 2002), as well
as traumatic brain and nerve injury (Sullivan et al, 2000;
Hausmann et al, 2002). Furthermore, there are first indica-
tions that creatine supplementation results in less UV-in-
duced mitochondrial DNA mutations in skin cells (Krutmann,
2001).
Despite the important function of creatine as an essential
energy precursor, the endogenous synthesis of creatine in
humans is not sufficient and creatine has to be supple-
mented by daily food intake, especially fish and meat.
Moreover, cutaneous cells may show signs of a declining
creatine level, probably caused by a stress and age-related
decline of dermal vascularization (Chung et al, 2002).
So far little is known about the question of whether oxi-
dative stress affects the CK system and/or creatine metab-
olism in healthy skin. But since there is a close relationship
of free radical reactions and energy metabolism (Nohl et al,
1997) and since CK, especially Mi-CK, is a prime target for
oxidative damage (Stachowiak et al, 1998; Dolder et al,
2001; Wendt et al, 2003), we investigated, however, the
functional importance of creatine and the CK system in
human skin and its modulation by creatine supplementa-
tion with a focus on oxidative stress conditions. Here, we
present results that creatine has marked protective effects
against oxidative stress on keratinocytes in vitro and against
UV-induced damage in vivo.
Results
CRT and CK in human skin The localization of CRTand CK
isoenzymes in human skin was examined by immunohisto-
chemistry. Cryosections were stained with isoenzyme-spe-
cific anti-CK, as well as with anti-CRT antibodies. Figure 1A
shows the localization of the soluble BB-CK isoform in the
epidermis of human skin. BB-CK is mainly located in the
cytosolic compartment of all epidermal layers (EL). In con-
trast, the dermis showed only little staining. Both controls
without primary antibody (Fig 1G) as well as immunohisto-
chemistry using an antibody against MM-CK (data not
shown) showed no signal in the epidermal skin layer. These
results are consistent with those published earlier (Schlattner
et al, 2002). Immunohistochemistry against uMi-CK also
showed significant staining of the epidermal layer of the hu-
man skin (Fig 1C). Anti-CRT antibodies reacted preferentially
with cell membranes of cells in the EL. Indirect immunoflu-
orescence using the polyclonal anti-human CRT antibody
(Fig 1E) revealed a distinct staining in the plasma membrane
of keratinocytes in the entire epidermis, whereas no staining
was found in the negative control (Fig 1G).
Strong BB-CK (Fig 2A) and uMi-CK (Fig 2C) staining was
also detectable in immunohistology of cell cultures using
primary human keratinocytes of healthy donors. In these
cells in vitro, BB-CK was mainly located in the cytosolic
compartment, but was also clustered in a particular pattern
around the nucleus. uMi-CK showed a more clustered
pattern, typical for mitochondria, as could be proven by
colocalization with an antibody against a mitochondrial
protein (Biotrend, Cologne, Germany). The negative control
remained unlabelled (Fig 2E).
Figure1
Immunohistochemical localization of creatine kinase (CK) and
creatine transporter (CRT) in human skin. Phase contrast (B, D, F, H)
and immunofluorescence microscopy images (A, C, E, G) of 7 mM
cryosections of healthy human skin are shown. Sections were stained
for BB-CK (cytosolic brain-type (ubiquitous) CK) (A), Mi-CK (mi-
tochondrial CK) (C), and CRT (E) with appropriate negative controls
(G, H). Goat-anti-rabbit IgG AlexaFluor488-conjugate was used as
secondary antibody (scale bars¼ 50 mm).
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Human epidermal volar forearm skin was isolated by the
suction blister technique from the untreated control site and
from both the placebo-treated and sites treated with a 0.1%
creatine-containing formulation for 1 wk, respectively. Fig-
ure 3 shows a representative western blot analysis of CK
isoenzymes and CRT taken from suction blister epidermis
cells of the appropriate skin site (Fig 3A) in comparison with
proteins from human primary keratinocytes in vitro (Fig 3B
and C). For CRT, a distinct band with an apparent molecular
weight of 70 kDa was found (Fig 3A). The detectable stain-
ing intensity of CRT in blister epidermis was, however, not
affected by any of the treatments, e.g.,  creatine (Fig 3A).
Samples of cellular extracts from identical suction blister
epidermis showed no staining using an antibody against
MM-CK (data not shown). In contrast, for BB-CK, a clear
signal of about 45 kDa was detectable in suction blisters as
well as in human primary keratinocytes (Fig 3B). Mi-CK
(about 40 kDa) was also detected in cells from suction blis-
ters and in human primary keratinocytes (Fig 3C).
Furthermore, the cellular uptake of creatine was meas-
ured using 14C-labelled creatine (Fig 4). A strong increase of
14C-creatine inside keratinocytes can be observed within
60 min. The addition of 2 mM guanidionopropionic acid
(GPA) after 20 min, a competitive inhibitor of the CRT, sig-
nificantly reduced creatine uptake.
CK enzymatic activity studies The activity of total CK was
examined in extracts of different cell types of human skin
(Table I). Analysis of specific CK activity in extracts of hu-
man dermal fibroblasts contrasted to the relatively high CK
Figure 2
Immunohistochemical localization of creatine kinase (CK) in hu-
man primary keratinocytes. Primary human keratinocytes obtained
from healthy donors were double stained for BB-CK (cytosolic brain-
type (ubiquitous) CK) (green fluorescence) and mitochondria (red flu-
orescence) (A) following methanol–acetone fixation with appropriate
negative control (E). Further keratinocytes were stained for both Mi-CK
(mitochondrial CK) (green fluorescence) and mitochondria (red fluores-
cence) (C) following methanol–acetone fixation. B, D, and F show
phase contrast images. Goat-anti-rabbit IgG AlexaFluor488- and goat-
anti-mouse IgG AlexaFluor546-conjugate were used as secondary an-
tibody (scale bars¼50 mm).
Figure3
Expression of creatine transporter (CRT) and creatine kinase (CK)
isoforms BB (brain-type (ubiquitous)) and Mi (mitochondrial) in
suction blister epidermis and primary keratinocytes. Western blot
analysis of CRT (A), BB-CK (B), and Mi-CK (C). Human suction blister
epidermis of untreated (lanes 1, 2), creatine- (lanes 5, 6), and placebo-
treated skin sites (lanes 3, 4) were isolated and separated by SDS-
PAGE. In western blot analysis, 10 mg of total protein was loaded per
lane as indicated and CRT was detected (A). b indicates a molecular
weight of about 70 kDa for CRT. Further human suction blister epider-
mis of an untreated skin site (lane 1 in B and C) and cell lysates (lanes 2,
3 in B and C) were separated by SDS-PAGE. In western blot analysis,
15 mg (for the anti-Mi-CK blots, C) or 20 mg (for the anti-BB-CK blots, B)
of total protein was loaded per lane as indicated and BB-CK (B) and Mi-
CK (C) were detected. Isolated BB-CK (lane 4) served as a positive
control in B. As negative control no primary antibody was used (lane 5
in B and lane 4 in C, negative). b indicates a molecular weight of about
45kDa for BB-CK (B) and 40 kDA for Mi-CK (C). Molecular weight
standards were used from Bio-Rad (Munich, Germany; A: Kaleido-
scope, B and C: Precision Plus, dual color). All western blots were
repeated three to five times and representative blots were chosen as
figures.
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activity in human keratinocytes, both obtained from healthy
donors. These data correlated with histological findings
showing a lower CK expression in human dermal cells (Fig
1) in comparison with the relatively high expression (Fig 2A)
found in human keratinocytes. The fluid extracted from
suction blisters also showed some CK activity (Paavonen
et al, 1988). All data were normalized relative to the total
amount of proteins.
To investigate age-related differences, CK activity of ep-
idermal skin cells obtained from young (not older than 35 y)
and old human donors (not younger than 65 y) were analy-
zed. We observed a substantial but not significant decline of
CK activity in cells obtained from old donors (n¼10), re-
duced to 84% (  26%) in comparison with the activity
in cells from young donors (n¼ 10), which were set to be
100% (  23%) (data not shown).
Modulation of CK activity and cellular uptake of ex-
ogenous creatine To evaluate the impact of creatine
supplementation, the activity of BB-CK was determined
following the incubation of keratinocytes with creatine in
comparison with untreated control keratinocytes (Fig 5).
Pre-loading of old donor cells with 150 mM creatine for 24 h
resulted in a statistically significant increase (þ 23%) in
specific CK activity in comparison with untreated cells
(100%). The protection of CK in young donor cells following
preloading with 150 mM creatine was only marginal (Fig 5).
Mi-CK seemed to have a higher specific activity com-
pared with cytosolic CK and was further stimulated by
creatine preloading (Table II). In order to exclude BB-CK
contamination in the organelle fractions, western blot
analysis was carried out, with both of the cytosolic and
the organelle fraction. BB-CK could only be detected in the
cytosolic fraction, whereas Mi-CK was only found in the
organelle fraction (data not shown).
We also obtained evidence that creatine predominantly
protected Mi-CK against H2O2 stress conditions (Fig 6A).
H2O2, even at small concentrations of 1 and 55 mM (as di-
rect oxidative stress), caused a significant decrease in the
CK activity of about 40% and 50% (open bars), respectively,
compared with the untreated control (100%). Pre-treatment
of keratinocytes with 150 mM creatine (closed bars) prior
to H2O2 incubation improved CK activity by 10% (at 1 mM
H2O2) or 19% (at 55 mM H2O2) when compared with un-
treated control, indicating a protection of the enzyme
against oxidative damage by creatine.
H2O2 concentrations were chosen according to our own
pilot experiments and literature data. Our cell vitality tests
with dermal fibroblasts showed that H2O2 concentrations
higher than 100 mM might lethally shock skin cells, in par-
ticular the older the donors are (data not shown). In addition,
we were interested in a senescent phenotype that was ob-
served by different studies in human fibroblasts applying
H2O2 in the low micromolar range (Chen and Ames, 1994;
Bladier et al, 1997; Chen et al, 1998). Thus, the concentra-
tion range of 1–55 mM H2O2 that we have chosen for our
study should resemble levels of oxidative stress that could
occur during the human aging processes.
We examined no antioxidative properties of creatine in
concentrations up to 450 mM in a cell-free assay (Fig 6B).
The assay performed estimates the radical scavenging ca-
pacity of creatine and vitamin C served as a positive control.
Cellular responses in human keratinocytes following
UVA-induced oxidative stress and protection by crea-
tine The formation of intracellular soluble peroxides in
keratinocytes from old donors (n¼9) following UVA radia-
tion is demonstrated in Fig 7A. Using doses of UVA radi-
ation of 5, 10, and 20 J per cm2, the level of intracellular
peroxides measured by dichlorodihydrofluorescein (DCHF)
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Figure 4
Cellular uptake of creatine. The uptake was measured by addition of
14C-labelled creatine (  ) to human primary keratinocytes. At the time
indicated by the arrow, 2 mM guanidinoproionic acid (GPA), a com-
petitive inhibitor of creatine uptake, was added ( ).
Table I. CK activity in human skin cells
Fibroblasts
Suction
blister ﬂuid Keratinocytes
Creatine kinase
activity/protein (EU)
0.9  0.17 0.7  0.25 7.3  1.71
Cytosolic extracts of early passaged cultivated dermal fibroblasts
(n¼ 6), suction blister fluid (n¼ 6) and primary human keratinocytes
(n¼ 17) obtained from healthy donors were analyzed in a CK activity
assay. Data represent the mean  SD.
CK, creatine kinase; EU, mmol PCr (phosphocreatine) per s per mg
protein at 251C.
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Figure5
Creatine supplementation and creatine kinase (CK) activity in hu-
man keratinocytes. Cytosolic extracts of early passaged cultivated
primary human keratinocytes obtained from old (n¼13; not younger
than 65 y) and young donors (n¼8; not older than 35 y) were incubated
with 150 mM creatine for 24 h in culture medium and subsequently
investigated for CK activity (þ , significant difference; po0.05). Error
bars indicate standard deviation (SD).
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fluorescence increased significantly in a concentration-
dependent manner to values up to 328%, respectively,
compared with the non-irradiated control cells (Fig 7A).
Monobromobimane (MBrB) fluorescence as an indicator of
intracellular thiol levels (Fig 7B) revealed a dose dependent
significant decline in total cellular thiol groups after UVA
radiation (5, 10, and 20 J per cm2) with keratinocytes from
old donors (n¼ 7) reaching values as low as 61%, com-
pared with non-irradiated control cells (100%). With regard
to UV-induced damage in mitochondrial energy supply,
mitochondrial membrane potential (MMP) (JC1-fluores-
cence) of control cells (non-irradiated keratinocytes) and
UVA-irradiated keratinocytes from old (not younger than
Table II. CK activity in cytosolic and organelle fractions with
and without creatine incubation
Cytosol
Cytosol
þ 150 lM
creatine Organelles
Organelles
þ150 lM
creatine
Creatine
kinase
activity/
protein (EU)
1.1  1.5 1.2  1.5 5.7  1.7 7.0  2.5
Primary human keratinocytes obtained from healthy old donors (n¼ 3)
were loaded with creatine (150 mM for 24 h) in comparison to untreated
control cells before organelle separation. Afterwards CK activity of the
cytosolic and organelle containing fraction was investigated. Data rep-
resent the mean  SD.
CK, creatine kinase; EU, mmol PCr (phosphocreatine) per s per mg
protein at 251C.
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Figure7
Modulation in cellular mechanisms of human keratinocytes fol-
lowing ultraviolet A (UVA) irradiation. Three different physiological
parameters were analyzed in early passaged cultivated primary human
keratinocytes obtained from healthy old donors following different dos-
es of UVA irradiation (5, 10, and 20 J per cm2). The formation of soluble
peroxides (A) was measured by dichlorodihydrofluorescein (DCHF) flu-
orescence in cells from nine healthy donors. Measurement of intracel-
lular thiols (B) in cells from seven donors used monobromobimane as
fluorescent dye. Mitochondrial membrane potential (MMP) in keratin-
ocytes from ten donors was detected by evaluation of 5,50,6,60-tetra-
chloro-1,10,3,30-tetraethyl-benzimidazol-carbocyanine iodide (JC-1)
fluorescence (C). All fluorescent data represent the mean  SD and
were related to appropriate cell number and qualified on non-irradiated
control (¼ 100%) (þ , significant difference; po0.05).
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Figure 6
Inhibition of creatine kinase (CK) activity of human keratinocytes
by H2O2 and protection by exogenous creatine. Measurement of CK
activity (A) of cytosolic extracts of early passaged cultivated primary
human keratinocytes obtained from healthy donors (n¼ 3) using differ-
ent low doses of H2O2 as mild oxidative stress (open bars). Preloading
of appropriate keratinocytes with creatine (150 mM for 24 h) prior to
H2O2 stress is shown in closed bars. Data represent the mean  SD
and were normalized on unstressed control levels (¼ 100%). No an-
tioxidative properties (B) were observed for creatine concentrations up
to 450 mM, compared with vitamin C as a positive control (all data n¼3)
(þ , significant difference; po0.05).
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65 y) donors (n¼10) were evaluated as shown in Fig 7C.
The MMP decreased significantly following irradiation with 5
J per cm2 by up to 80.3% relative to the non-irradiated
control. UVA irradiation with higher doses (10 and 20 J per
cm2) led to comparable reduction of MMP values.
On the basis of several promising in vitro results (data not
shown) concerning the protective effect of creatine on the
MMP, we performed ex vivo studies on human suction blis-
ter epidermis to evaluate the protective effects of a topical
creatine/creatinine application in stabilizing mitochondrial
function.
Healthy old volunteers (average age of 65.2 y) topically
applied a stabilized creatine formulation (1% creatine/0.5%
creatinine) twice a day for 4 wk on their upper arm. After-
wards, epidermal cells were isolated via suction blister and
irradiated to examine MMP (Fig 8). In response to the irra-
diation with 15 J per cm2 UVA light, epidermal cells from
placebo-treated skin sites showed a decline in their MMP
by 16.3% compared with non-irradiated control cells. In
contrast, cells from the creatine/creatinine-treated skin sites
showed a statistically significant maintenance of their MMP,
even after irradiation compared with the irradiated placebo
control cells (Fig 8).
Discussion
During daily human life, the skin is particularly exposed to
different environmental stressors, which can more or less
influence the physiological behavior of cutaneous cells and
thus the skin as an entire organ. Any disturbance in the
cellular homeostasis is usually counteracted by various in-
trinsic mechanisms, aiming to rebalance the deregulated
physiological processes rapidly. For this purpose, each
single cell is provided with several repair mechanisms,
depending mostly on a sufficient energy supply to the
appropriate cell and tissue. For various cells and organs,
it has been shown that changes in the cellular energy state
occur during aging, especially in muscle tissue (Carmeli
et al, 2002). Krebs cycle enzymes in skeletal muscle of old
rats (Ermini, 1976), e.g., as well as important compounds for
cellular energetics, such as citrate, PCr, and ATP in aged
human skeletal muscles (Pastoris et al, 2000), are reported
to decline notably.
This study shows the significance of the PCr/CK system
for epidermal energy supply and the beneficial effects of
creatine supplementation both in vitro and in vivo.
We found that both creatine kinase subtypes, BB-CK and
Mi-CK, as well as CRT, are expressed in human skin, show-
ing high levels in the epidermis but less in the dermis (Fig 1).
This confirms a recent publication from Schlattner et al
(2002) on BB-CK in murine and human cells. Regarding
the localization in the epidermis, there was no gradient of
CRT, BB-CK, or Mi-CK detectable. These data clearly
demonstrate that human skin contains a functional PCr/CK
system.
We measured total CK activities of dermal fibroblasts,
keratinocytes, and suction blister fluids obtained from do-
nors of different ages. In accordance with histological find-
ings, the highest enzyme activity was found in keratinocytes
(Table I), again indicating an increased energy turnover in
epidermal cells. The lower BB-CK activity in dermal fibro-
blasts (Fig 1 and Table I) is likely due to a lower expression
of this enzyme in these cells in vivo (Fig 1).
Furthermore, we observed a lower total CK activity in
epidermal skin cells obtained from old donors. These data
correlate with results from different experiments using skel-
etal muscle and heart muscle, clearly showing that both PCr
amount (Verzar and Ermini, 1970; McCully et al, 1991) and
CK activity decrease with age (Steinhagen-Thiessen and
Hilz, 1976; Bogatskaia and Shegera, 1981). This decline in
skin CK activity may be caused by the generation of ROS
during cutaneous aging (Harman, 1956; Dolder et al, 2001).
This is supported by the fact that CK, specifically Mi-CK, is
a primary target for ROS, especially peroxynitrite (Stacho-
wiak et al, 1998). It is fully in line with the observed
substantial inactivation of CK after application of low
concentrations of H2O2 (Fig 6A). Oxidative stress and free
radical reactions in skin cells evolve during inflammation or
as by-products of mitochondrial respiration, especially dur-
ing aging (Sohal, 1991; Lee, 1997). Enhanced stress con-
ditions in turn may cause further damages in mitochondria
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Figure 8
Mitochondrial membrane potential (MMP) pro-
tection following topical application of crea-
tine/creatinine. Healthy old volunteers (n¼8;
average age of 65.2 y) topically applied a 1%
creatine/0.5% creatinine-containing formulation
twice a day for a period of 4 wk. Human suction
blister epidermis of placebo- and verum-treated
skin sites was isolated and epidermal cells sep-
arated for fluorescent evaluation of MMP. All flu-
orescent data represent the mean  SD and were
related to appropriate cell number and to placebo-
treated, non-irradiated control (¼ 100%). The two
bars on the left represent non-irradiated cells; the
two bars on the right represent ultraviolet (UV)-
irradiated cells ( indicates irradiation; irradiation
with 15 J per cm2 once after cell isolation) (þ ,
significant difference; po0.05).
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and can reduce cellular energy capacity, as evaluated by
parameters like MMP (Fig 7C). With regard to the sensitivity
of CK activity towards oxidative stress, energetic deficien-
cies in old keratinocytes might be caused by a loss of Mi-
CK activity, which seems of major importance in keratin-
ocytes (Table II). It is known from the literature (Ronquist
et al, 2003) and our own experiments (data not shown) that
there are only slight differences in mitochondrial number
between keratinocytes and dermal fibroblasts; however,
particularly keratinocytes contain more structurally abnor-
mal mitochondria. It can be speculated that this change in
mitochondrial morphology and function may be partially
caused by the limited availability of substrates like creatine
and a resulting destabilization of octameric Mi-CK (Table II).
Any lack in its function may directly affect energy supply in
the skin and further accelerate cutaneous aging.
In order to investigate oxidative stress reactions, we ir-
radiated human skin cells from old donors using different
doses of UVA light, known to induce the formation of ROS
(Scharffetter-Kochanek et al, 1997). Even low doses of 5 J
per cm2 UVA substantially elevated cellular peroxide levels
(Fig 7A). This effect was accompanied by both a decrease in
the level of intracellular thiols (Niggli and Applegate, 1997),
one main parameter of the non-enzymatic antioxidant sys-
tem, as well as a decline in the MMP, indicating ROS-me-
diated damage to mitochondrial energy supply (Fig 7B, C).
We finally demonstrated the positive effects of creatine
supplementation. Obviously, human keratinocytes are able
to take up creatine (Fig 4). This accumulation of supple-
mented creatine in keratinocytes leads to a significant in-
crease in total CK activity (Fig 5) and substantially stabilizes
and protects CK activity in vitro even under conditions of
direct oxidative stress (Fig 6A). Our data imply a correlation
between the observed substantial decline of total CK ac-
tivity in epidermal cells and of oxidative stress conditions,
comparable to those that occur during aging. It can also be
speculated that the intrinsic level of epidermal creatine de-
clines as a function of age mainly caused by a lack of vas-
cularization (Chung et al, 2002). This conclusion seems to
be justified, because elevating cellular uptake of creatine,
as a substrate for CK, reversed the age-related loss in CK
enzyme activity (Fig 6A). This may be due to a protection of
the enzymes, both BB-CK and Mi-CK, by creatine against
oxygen-radical damage (Lawler et al, 2002) and we have
strong evidence that this effect is not caused by any an-
tioxidative property of creatine itself (Fig 6B). Any antioxi-
dative or other indirect effects of creatine mostly occur
when creatine is applied in high concentrations, because it
may additionally influence the availability of methyl groups
for protein synthesis by sparing S-adenosyl-methionine
(Stead et al, 2001). In our experiments using a low concen-
tration of creatine (150 mM), these antioxidative effects are
negligible and one is likely looking at direct effects of crea-
tine as an energy precursor for keratinocytes. At the chosen
concentration of creatine, CRT is well saturated (K(m) (Mi-
chaelis–Menten constant) of CRT for creatine is in the range
of approximately 20–30 mM) (Dodd and Christie, 2001; Peral
et al, 2002) and thus skin cells can rapidly accumulate
creatine. This cellular uptake of creatine facilitated by the
creatine transporter and the enrichment of applied creatine
in human skin cells (Fig 4) can also explain the effects of
creatine on the MMP (Fig 8; Daly and Seifter, 1980). Gen-
erally, CK is specifically located at places of energy demand
and energy production and plays an important role in the
energetics of Ca2þ -homeostasis and mitochondrial mem-
brane stability (Wallimann et al, 1998). Thus, the protective
effect on mitochondria may be explained by the stabilization
of Mi-CK by creatine, even under conditions of oxidative
stress (Fig 6A). Mi-CK is a cuboidal-shaped octamer that
stabilizes and cross-links cristae- or inner/outer membranes
to form parallel membrane stacks. Mi-CK octamers and
creatine have been reported to modulate mitochondrial
permeability transition pore opening (Wallimann et al, 1998;
Dolder et al, 2003) in some organs. These findings corrob-
orate with data by Krutmann and colleagues, clearly show-
ing the protective role of creatine treatment on the formation
of mitochondrial common deletion mutation in skin cells
(Krutmann, 2001). The common deletion mutation is well
known to be closely related to mitochondrial decay in der-
mal aging as well. With increasing age, fibroblasts switch
from a matrix-producing to a matrix-degrading phenotype
(Campisi, 1998). One possible explanation may be a decline
in cellular energy supply (Hagen et al, 1997; Rottenberg and
Wu, 1997). In fact, we have preliminary evidence that sta-
bilizing mitochondrial energetic capacity by creatine appli-
cation in vitro and in vivo can substantially restimulate
synthesis of dermal matrix components like collagen (data
not shown).
Our data indicate that the epidermal creatine system,
which is very important for cellular energy metabolism, ob-
viously declines under oxidative stress conditions, including
skin aging processes. Application of creatine to skin cells
in vitro and in vivo can recharge these cells energetically,
and thus protect them against free radical-induced cell
damage. We are currently investigating further effects of a
topical creatine application using cosmetic and dermato-
logical formulations, especially for prophylaxis and treat-
ment of aging human skin.
Material and Methods
Cell culture Human skin biopsies were isolated from healthy old
(not younger than 65 y) and young (not older than 35 y) donors.
Primary human dermal cells were enzymatically prepared using a
standardized dispase (Boehringer Mannheim, Mannheim, Germa-
ny) digestion technique. The dermal fraction was cultured at 371C
and 7% CO2 (in air) in six-well plates containing Dulbecco’s mod-
ified Eagle’s medium (Life Technologies, Eggenstein, Germany)
supplemented with 10% fetal calf serum (Life Technologies) and
penicillin/streptomycin (50 IU per mL; 50 mg per mL, Life Technol-
ogies). After 5–6 wk of incubation, confluently grown fibroblasts
were seeded into 96-well microtiter plates (Greiner, Frickenhausen,
Germany). Human primary keratinocytes were isolated from the
epidermis through trypsin digestion (PAA, Linz, Austria) and cul-
tured in KGM-2 (Cambrex, Apen, Germany). After cells reached
a confluency of 50%–70%, keratinocytes were split 1:2. After 2–3 d
of incubation, cells were used for the experiments described
below.
Suction blister Epidermal roofs were harvested from suction blis-
ters of human skin (Kiistala, 1968). For blistering on an area of
about 5 mm in diameter, a vacuum of 300 mbar was used for about
2 h. Primary skin cells were then harvested by trypsin digestion
from the freshly prepared epidermal biopsies.
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UVA source UVA irradiation (5, 10, 15, and 20 J per cm2 for one
time) was performed using a Dermalight 2020 illuminator (Dr Ho¨nle,
Planegg, Germany). The emitted dose was quantitated using a UV-
radiometer IL1700 (International Light, Newburyport, Massachusetts).
Evaluation of MMP The MMP was measured using the dye
5,50,6,60-tetrachloro-1,10,3,30-tetraethyl-benzimidazol-carbocyanine
iodide (JC-1) (Molecular Probes, Eugene, Oregon), which can be
used to specifically quantify alterations in MMP in living cells
(Cossarizza et al, 1993). Fluorescence was measured spectromet-
rically (EX 485 nm/EM 530 nm and EM 485 nm/EM 590 nm; Cyto-
fluor II, Perseptive Biosystems, Freiburg, Germany). All data
presented were background corrected by measuring fluorescent
values without cells.
Evaluation of antioxidative properties (ABTS assay) Antioxida-
tive properties of creatine in comparison with vitamin C were in-
vestigated as described in the literature by Re et al (1999).
Determination of soluble peroxides Intracellular peroxides were
detected spectrometrically in a Cytofluor II (Perseptive Biosystems)
using the probe Dichlorodihydrofluoresceindiacetat (DCHF-DA),
which specifically reacts with peroxides (Rosenkranz et al, 1992;
Suzuki et al, 1997). The quantification of specific fluorescence (EX
485 nm/EM 530 nm) in relation to cell number was performed in 96-
well microtiter plates also using the Cytofluor II. All data presented
were background corrected by measuring fluorescent values with-
out cells.
Evaluation of intracellular thiol groups Intracellular thiol groups
were measured spectrometrically in a Cytofluor II (Perseptive Bio-
systems) using the probe MBrB, which specifically reacts with thiol
groups (Durand and Olive, 1983; Cotgreave et al, 1988). The
quantification of the specific fluorescence (EX 390 nm/EM 460 nm)
in relation to cell number was performed in 96-well microtiter plates
using the Cytofluor II. All data presented were background cor-
rected by measuring fluorescent values without cells.
Incubation with creatine Creatine (Goldschmidt, Essen, Germa-
ny; SKW Trostberg, Freising-Weihenstephan, Germany; Sigma,
Munich, Germany) was added at a final concentration of 150 mM to
subconfluently grown (about 70% confluency) keratinocytes. 150
mM creatine is slightly above normal serum concentrations (30–100
mM) (Vanakoski et al, 1998; Schedel et al, 1999). Creatine was
prepared in KGM-2, filtered, and then added to the culture medi-
um. After 24 h incubation cells were washed twice with phosphate-
buffered saline (PBS) and used for further experiments.
Uptake of 14C-creatine 14C-creatine (Biotrend; activity of 1 mCi
per mL) was added to human primary keratinocytes in six-well
plates, following washing once with PBS. GPA (Sigma) was used
as a competitive inhibitor for CRT at a concentration of 2 mM and
was added after 20 min of incubation with 14C-creatine. Following
incubation, cells were washed three times with PBS and cyto-
plasmatic extracts were measured in a liquid scintillation counter
(Pharmacia, Freiburg, Germany) and 14C-counts were normalized
on total protein amount (mg).
Topical application of creatine Volunteers (average age of 65.2
y) topically applied a formulation containing either 0.1% creatine
for western blot-analysis or 1% creatine/0.5% creatinine (Gol-
dschmidt, SKW Trostberg) versus a placebo formulation without
creatine and creatinine twice a day for a period of 1 or 4 wk,
respectively. Creatinine was added to the formulation to maintain a
chemically balanced quantity of highly reactive creatine, which, if
not stabilized, readily undergoes rearrangement to creatinine in
aqueous systems. The study was conducted according to the
Declaration of Helsinki Principles and participants gave their
written informed consent. All experiments were performed and
approved by the R&D, Beiersdorf AG, Hamburg, Germany.
Antibodies and immunoblotting Proteins from cell extracts
(10 mg per lane) were separated by polyacrylamide gel electrophoresis
under denaturing conditions on 10% SDS-PAGE gels. Subse-
quently, the proteins were electrotransferred onto nitrocellulose or
polyvinylidine fluoride membranes and, after blocking with 10%
milk powder, incubated with primary anti-BB, anti-MM, or anti-Mi-
CK antibodies, as well as with anti-creatine-transporter antibodies
(anti-human anti-BB-CK, anti-MM-CK, and anti-CRT antibodies
from Biotrend (Ko¨ln, Germany), anti-human Mi-CK described in
Schlattner et al, 2002), followed by secondary antibodies (anti-
rabbit IgG, Sigma), the latter conjugated to horseradish peroxidase
(HRP). The protein bands, blotted on nitrocellulose or PVDF sheets,
were visualized using the Lumilight Plus Western Blot Detection Kit
(Roche, Mannheim, Germany).
Immunohistology Samples of human skin were embedded in
TissueTek (Leica, Nussloch, Germany), frozen in liquid nitrogen,
and cut with a microtome into 5–7 mm thin sections. After fixation in
methanol/acetone (1:1) at 201C for 10 min, the sections were
washed three times with PBS and blocked in 1% bovine serum
albumin (BSA). Sections were then incubated overnight at 41C in a
moist chamber with primary antibodies against either BB-CK, Mi-
CK, or CRT diluted in PBS containing 0.1% BSA. All polyclonal
antibodies (BB-CK and CRT: Biotrend, Mi-CK: Schlattner et al,
2002) were diluted 1:1000. For colocalization a monoclonal mouse-
anti-human antibody against a 60 kDa mitochondrial antigen (Bio-
trend) was used in a 1:1000 dilution. After washing three times in
PBS, sections were incubated with secondary antibodies (Alexa-
Fluor 488 goat-anti-rabbit IgG or AlexaFluor 546 goat-anti-mouse
IgG, Molecular Probes, Eugene, Oregon) diluted 1:1000 for 1 h at
room temperature in a moist chamber. Sections were washed three
times in PBS and mounted in Mowiol (Calbiochem, San Diego,
California). Fluorescence images of sections were recorded on a
fluorescence microscope (Carl Zeiss, Oberkochen, Germany) with
an attached closed-circuit display (CCD) camera.
CK activity assay Cytoplasmic extracts (10 mL) of creatine-treat-
ed and untreated control cells were used in a creatine kinase assay
(Sigma). 50 mL creatine solution was added to one sample of each
cytoplasmic extract (test), and 50 mL tris(hydroxymethyl) Metha-
namine (TRIZMA) buffer was added to another sample (blank). Af-
ter addition of 50 mL water and 5 min incubation at 371C, 4 mL ATP-
glutathione was added and the samples were incubated at 371C
for 1 h. The reaction was then stopped with 80 mL 20% tricchloro-
acetic acid (TCA) and filtered through a multiscreen plate (Millipore,
Billerica, Massachusetts). After addition of 200 mL water, 50 mL acid
molybdate, and 12.5 mL Fisk&Subarow reducer to 50 mL of each
sample, they were incubated at room temperature for 30 min. Fi-
nally, the absorbance at 700 nm was measured, the amount of
phosphate (in mg) was determined according to a previously es-
tablished standard curve, and the difference (Dmg phosphate) be-
tween blank and test related to CK activity units. All data were
normalized relative to the total amount of proteins.
Isolation and preparation of cytosolic and mitochondrial frac-
tions Experiments were performed according to the manufactur-
er’s instructions (Merck KgaA, Darmstadt, Germany).
Statistical analysis Statistical evaluation of data was performed
using a two-tailed Student’s t test. Normal distribution was
checked via the Shapiro–Wilks-W-Test.
Error bars indicate standard deviation (SD).
DOI: 10.1111/j.0022-202X.2004.23522.x
Manuscript received March 2, 2004; revised July 29, 2004; accepted
for publication August 2, 2004
Address correspondence to: Dr Thomas Blatt, R&D Cosmed, Be-
iersdorf AG, Unnastrasse 48, D-20245 Hamburg, Germany. Email:
thomas.blatt@beiersdorf.com
450 LENZ ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
References
Balsom PD, Soderlund K, Ekbolm B: Creatine in humans with special reference to
creatine supplementation. Sports Med 18:268–280, 1994
Bessman SP, Carpenter CL: The creatine–creatine phosphate energy shuttle.
Annu Rev Biochem 54:831–862, 1985
Bladier C, Wolvetang EJ, Hutchinson P, deHaan JB, Kola I: Response of a primary
human fibroblasts cell line to H2O2: Senescence like growth arrest or
apoptosis? Cell Growth Differ 8:589–598, 1997
Bogatskaia LN, Shegera VA: Creatine kinase activity and isoenzymic spectrum of
myocardium creatine kinase in rats of different age. Ukr Biokhim 53:
71–74, 1981
Campisi J: The role of cellular senescence in skin aging. J Investig Dermatol
Symp Proc 3:1–5, 1998
Carmeli E, Coleman R, Reznick AZ: The biochemistry of ageing muscle. Exp
Gerontol 37:477–489, 2002
Chen Q, Ames BN: Senescence-like growth arrest induced by hydrogen peroxide
in human diploid fibroblasts F65 cells. Proc Natl Acad Sci USA 91:
4130–4134, 1994
Chen Q, Bartholomew JC, Campisi J, Acosta M, Reagan JD, Ames BN: Molec-
ular analysis of H2O2-induced senescent-like growth arrest in normal hu-
man fibroblasts: p53 and Rb control G1 arrest but not cell replication.
Biochem J 332:43–50, 1998
Chung JH, Yano K, Lee MK, et al: Differential effects of photoageing vs intrinsic
ageing on the vascularization of human skin. Arch Dermatol 138:
1437–1442, 2002
Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C: A new method
for the cytofluorimetric analysis of mitochondrial membrane potential us-
ing the J-aggregate forming lipophilic cation 5,50,6,60-tetrachloro-1,10,
3,30-tetraethylbenzimidazolcarbo-cyanine iodide (JC-1). Biochem Biophys
Res Commun 197:40–45, 1993
Cotgreave IA, Weis M, Berggren M, Sandy MS, Moldeus PW: Determination of
the intracellular protein thiol distribution of hepatocytes using monobro-
mobimane derivatisation of intact cells and isolated subcellular fractions.
J Biochem Biophys Methods 16:247–254, 1988
Crozatier B, Badoual T, Boehm E, et al: Role of creatine kinase in cardiac ex-
citation–contraction coupling: Studies in creatine kinase-deficient mice.
FASEB J 16:653–660, 2002
Daly MM, Seifter S: Uptake of creatine by cultured cells. Arch Biochem Biophys
203:317–324, 1980
Dodd JR, Christie DL: Cysteine 144 in the third transmembrane domain of the
creatine transporter is located close to a substrate-binding site. J Biol
Chem 276:46983–46988, 2001
Dolder M, Walzel B, Speer O, Schlattner U, Wallimann T: Inhibition of the mi-
tochondrial permeability transition by creatine kinase substrates. Require-
ment for microcompartmentation. J Biol Chem 278:17760–17766, 2003
Dolder M, Wendt S, Wallimann T: Mitochondrial creatine kinase in contact sites:
Interaction with porin and adenine nucleotide translocase, role in per-
meability transition and sensitivity to oxidative damage. Biol Signal Re-
cept 10:93–111, 2001
Durand RE, Olive PL: Flow cytometry techniques for studying cellular thiols.
Radiat Res 95:456–470, 1983
Ermini M: Ageing changes in mammalian skeletal muscle: Biochemical studies.
Gerontology 22:301–316, 1976
Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ: Pathophysiology
of premature skin ageing induced by ultraviolet light. N Engl J Med
337:1419–1428, 1997
Gorselink M, Drost MR, Coumans WA, van Kranenburg GP, Hesselink RP, van der
Vusse GJ: Impaired muscular contractile performance and adenine nuc-
leotide handling in creatine kinase-deficient mice. Am J Physiol End-
ocrinol Metab 281:E619–E625, 2001
Hagen TM, Yowe DL, Bartholomew JC, Wehr CM, Do KL, Park JY, Ames BN:
Mitochondrial decay in hepatocytes from old rats: Membrane potential
declines, heterogeneity and oxidants increase. Proc Natl Acad Sci USA
94:3064–3069, 1997
Harman D: Ageing: A theory based on free radical and radiation chemistry.
J Gerontol 11:298–300, 1956
Hausmann ON, Fouad K, Wallimann T, Schwab ME: Protective effects of oral
creatine supplementation on spinal cord injury in rats. Spinal Cord 40:
449–456, 2002
Janssen E, Terzic A, Wieringa B, Dzeja PP: Impaired intracellular energetic com-
munication in muscles from creatine kinase and adenylate kinase (M-CK/
AK1) double knock-out mice. J Biol Chem 278:30441–30449, 2003
Kiistala U: Suction blister device for separation of viable epidermis from dermis.
J Invest Dermatol 50:129–137, 1968
Krutmann J: New developments in photoprotection of human skin. Skin Pharma-
col Appl Skin Physiol 14:401–407, 2001
Lawler JM, Barnes WS, Wu G, Song W, Demaree S: Direct antioxidant properties
of creatine. Biochem Biophys Res Commun 290:47–52, 2002
Lee HC: Role of Mitochondria in human ageing. J Biomed Sci 4:319–326, 1997
Leuzzi V: Inborn errors of creatine metabolism and epilepsy: Clinical features,
diagnosis, and treatment. J Child Neurol 17:3S89–3S97; discussion 3S97,
2002
McCully KK, Forciea MA, Hack LM, et al: Muscle metabolism in older subjects
using 32P magnetic resonance spectroscopy. Can J Physiol Pharmacol
69:576–580, 1991
Niggli HJ, Applegate LA: Glutathione response after UVA irradiation in mitotic and
postmitotic human skin fibroblasts and keratinocytes. Photochem Pho-
tobiol 65:680–684, 1997
Nohl H, Staniek K, Gille L: Imbalance of oxygen activation and energy
metabolism as a consequence or mediator of ageing. Exp Gerontol 32:
485–500, 1997
Paavonen T, Aronen H, Saarelainen I, Neittaanma¨ki H, Hjelm I, Kiistala U: The BB-
isozyme is a major component of creatine kinase in skin blister fluid. Brit J
Dermatol 118:753–757, 1988
Pastoris O, Boschi F, Verri M, et al: The effects of ageing on enzyme activities and
metabolite concentrations in skeletal muscle from sedentary male and
female subjects. Exp Gerontol 35:95–104, 2000
Peral MJ, Garcia-Delgado M, Calonge ML, et al: Human, rat and chicken small
intestinal Naþ–Cl-creatine transporter: Functional, molecular character-
ization and localization. J Physiol 545 (Pt 1):133–144, 2002
Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C: Antioxidant
activity applying an improved ABTS radical cation decolorization assay.
Free Rad Biol Med 26:1231–1237, 1999
Ronquist G, Andersson A, Bendsoe N, Falck B: Human epidermal energy me-
tabolism is functionally anaerobic. Exp Dermatol 12:572–579, 2003
Rosenkranz AR, Schmaldienst S, Stuhlmeier KM, Chen W, Knapp W, Zlabinger
GJ: A microplate assay for the detection of oxidative products using 20,70-
dichlorofluorescin-diacetate. J Immunol Methods 156:39–45, 1992
Rottenberg H, Wu S: Mitochondrial dysfunction in lymphocytes from old mice:
Enhanced activation of the permeability transition. Biochem Biophys Res
Commun 240:68–74, 1997
Scharffetter-Kochanek K, Wlaschek M, Brenneisen P, Schauen M, Blaudschun R,
Wenk J: UV-induced reactive oxygen species in photocarcinogenesis and
photoageing. Biol Chem 378:1247–1257, 1997
Schedel JM, Tanaka H, Kiyonaga A, Shindo M, Schutz Y: Acute creatine ingestion
in human: Consequences on serum creatine and creatinine concentra-
tions. Life Sci 65:2463–2470, 1999
Schlattner U, Mockli N, Speer O, Werner S, Wallimann T: Creatine kinase
and creatine transporter in normal, wounded, and diseased skin. J Invest
Dermatol 118:416–423, 2002
Sies H: Oxidative Stress. London: Academic Press, 1985
Snow RJ, Murphy RM: Creatine and the creatine transporter: A review. Mol Cell
Biochem 224:169–181, 2001
Sohal RS: Hydrogen peroxide production by mitochondria may be a biomarker of
ageing. Mech Ageing Dev 60:189–198, 1991
Speer O, Neukomm LJ, Murphy RM, et al: Creatine transporters: A reappraisal.
Mol Cell Biochem 256/257:407–424, 2004
Stachowiak O, Dolder M, Wallimann T, Richter C: Mitochondrial creatine kinase
is a prime target of peroxynitrite-induced modification and inactivation.
J Biol Chem 273:16694–16699, 1998
Stead LM, Au KP, Jacobs RL, Brosnan ME, Brosnan JT: Methylation demand and
homocysteine metabolism: Effects of dietary provision of creatine and
guanidinoacetate. Am J Physiol Endocrinol Metab 281:E1095–E1100,
2001
Steeghs K, Benders A, Oerlemans F, et al: Altered Ca2þ responses in muscles
with combined mitochondrial and cytosolic creatine kinase deficiencies.
Cell 89:93–103, 1997
Steinhagen-Thiessen E, Hilz H: The age-dependent decrease in creatine kinase
and aldolase activities in human striated muscle is not caused by an
accumulationn of faulty proteins. Mech Ageing Dev 5:447–457, 1976
Sullivan PG, Geiger JD, Mattson MP, Scheff SW: Dietary supplement creatine
protects against traumatic brain injury. Ann Neurol 48:723–729, 2000
Suzuki YJ, Forman HJ, Sevanian A: Oxidants as stimulators of signal transduct-
ion. Free Radic Biol Med 22:269–285, 1997
Vanakoski J, Kosunen V, Meririnne E, Seppala T: Creatine and caffeine in anaer-
obic and aerobic exercise: Effects on physical performance and phar-
macokinetic considerations. Int J Clin Pharmacol Ther 36:258–262, 1998
Verzar F, Ermini M: Decrease of creatine-phosphate restitution of muscle in old
age and the influence of glucose. Gerontologia 16:223–230, 1970
Walker JB: Creatine: Biosynthesis, regulation, and function. Adv Enzymol 50:
177–252, 1979
Wallimann T, Dolder M, Schlattner U, et al: Some new aspects of creatine kinase
(CK): Compartmentation, structure, function and regulation for cellular
APPLICATION OF CREATINE SUPPORTS CELLULAR ENERGY SUPPLY IN HUMAN SKIN 451124 : 2 FEBRUARY 2005
and mitochondrial bioenergetics and physiology. BioFactors 8:229–234,
1998
Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM: Intracellular com-
partmentation, structure and function of creatine kinase isoenzymes
in tissues with high and fluctuating energy demands: The ‘‘phospho-
creatine circuit’’ for cellular energy homeostasis. Biochem J 281:21–40,
1992
Wendt S, Schlattner U, Wallimann T: Differential effects of peroxynitrite on human
mitochondrial creatine kinase isoenzymes. Inactivation, octamer des-
tabilization, and identification of involved residues. J Biol Chem 278:
1125–1130, 2003
Wyss M, Schulze A: Health implications of creatine: Can oral creatine supple-
mentation protect against neurological and atherosclerotic disease? Ne-
uroscience 112:243–260, 2002
452 LENZ ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
